These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8038705)

  • 1. Interactions among prostaglandin receptors.
    Ashby B
    Receptor; 1994; 4(1):31-42. PubMed ID: 8038705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel mechanism of heterologous desensitization of adenylate cyclase: prostaglandins bind with different affinities to both stimulatory and inhibitory receptors on platelets.
    Ashby B
    Mol Pharmacol; 1990 Jul; 38(1):46-53. PubMed ID: 1695318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic AMP turnover in response to prostaglandins in intact platelets: evidence for separate stimulatory and inhibitory prostaglandin receptors.
    Ashby B
    Second Messengers Phosphoproteins; 1988; 12(1):45-57. PubMed ID: 2848122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Model of prostaglandin-regulated cyclic AMP metabolism in intact platelets: examination of time-dependent effects on adenylate cyclase and phosphodiesterase activities.
    Ashby B
    Mol Pharmacol; 1989 Dec; 36(6):866-73. PubMed ID: 2481225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of thromboxane antagonists on prostaglandin regulation of platelet adenylate cyclase.
    Ashby B
    Second Messengers Phosphoproteins; 1988-1989; 12(5-6):241-50. PubMed ID: 2483174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity.
    Namba T; Sugimoto Y; Negishi M; Irie A; Ushikubi F; Kakizuka A; Ito S; Ichikawa A; Narumiya S
    Nature; 1993 Sep; 365(6442):166-70. PubMed ID: 8396726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of adenylate cyclase stimulation by prostaglandin E receptor EP3 subtype isoforms with different efficiencies.
    Harazono A; Sugimoto Y; Ichikawa A; Negishi M
    Biochem Biophys Res Commun; 1994 May; 201(1):340-5. PubMed ID: 8198593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasticity of prostaglandin E2 receptor in human macrophages and the ternary complex of adenylate cyclase.
    Adolfs MJ; Bonta IL
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():459-62. PubMed ID: 2889337
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostacyclin-sensitive adenylate cyclase and prostacyclin binding sites in platelets and smooth muscle cells.
    Nicosia S; Oliva D; Bernini F; Fumagalli R
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():593-9. PubMed ID: 6328938
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization of adenosine receptors in human erythroleukemia cells and platelets: further evidence for heterogeneity of adenosine A2 receptor subtypes.
    Feoktistov I; Biaggioni I
    Mol Pharmacol; 1993 Jun; 43(6):909-14. PubMed ID: 8391117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin receptors coupled to adenylyl cyclase in the iris-ciliary body of rabbits, cats and cows.
    Bhattacherjee P; Rhodes L; Paterson CA
    Exp Eye Res; 1993 Mar; 56(3):327-33. PubMed ID: 8386102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 6-ketoprostaglandin E1 activates adenylate cyclase in human platelet membranes through prostacyclin receptors.
    Oliva D; Nicosia S
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():601-4. PubMed ID: 6328939
    [No Abstract]   [Full Text] [Related]  

  • 13. Signal transduction coupled to prostaglandin D2.
    Ito S; Negishi M; Sugama K; Okuda-Ashitaka E; Hayaishi O
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():371-4. PubMed ID: 1705384
    [No Abstract]   [Full Text] [Related]  

  • 14. Sensitization of adenylate cyclase by Galpha i/o-coupled receptors.
    Watts VJ; Neve KA
    Pharmacol Ther; 2005 Jun; 106(3):405-21. PubMed ID: 15922020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Affinities, selectivities, potencies, and intrinsic activities of natural and synthetic prostanoids using endogenous receptors: focus on DP class prostanoids.
    Sharif NA; Crider JY; Xu SX; Williams GW
    J Pharmacol Exp Ther; 2000 May; 293(2):321-8. PubMed ID: 10772998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory regulation of adenylate cyclase by prostaglandins.
    Aktories K; Schultz G; Jakobs KH
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():283-90. PubMed ID: 6133422
    [No Abstract]   [Full Text] [Related]  

  • 17. Distribution of prostaglandin IP and EP receptor subtypes and isoforms in platelets and human umbilical artery smooth muscle cells.
    Paul BZ; Ashby B; Sheth SB
    Br J Haematol; 1998 Sep; 102(5):1204-11. PubMed ID: 9753046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E1 and platelets.
    Bousser MG
    Biomedicine; 1973 Mar; 18(2):95-102. PubMed ID: 4354464
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of protein kinase C in ethanol-induced activation of adenylyl cyclase.
    Rabbani M; Nelson EJ; Hoffman PL; Tabakoff B
    Alcohol Clin Exp Res; 1999 Jan; 23(1):77-86. PubMed ID: 10029206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E receptors in myometrial cells.
    Asbóth G; Phaneuf S; López Bernal AL
    Acta Physiol Hung; 1997-1998; 85(1):39-50. PubMed ID: 9530435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.